Phosphoinositide 3-kinase signalling in lung disease: leucocytes and beyond

• Published in: Immunology Vol. 121; no. 4; pp. 448 - 461
• Main Authors: Medina-Tato, David A, Ward, Stephen G, Watson, Malcolm L
• Format: Journal Article
• Language: English
• Published: Oxford, UK Oxford, UK : Blackwell Publishing Ltd 01-08-2007; Blackwell Publishing Ltd; Blackwell Science Inc
• Subjects: asthma; Asthma - immunology; Humans; inflammation; Leukocytes - enzymology; lung disease; Lung Diseases - immunology; Phosphatidylinositol 3-Kinases - immunology; PI3K; Protein Isoforms - immunology; Pulmonary Disease, Chronic Obstructive - immunology; Respiratory Distress Syndrome, Adult - immunology; Review; Signal Transduction - immunology
• ISSN: 0019-2805; 1365-2567
• DOI: 10.1111/j.1365-2567.2007.02663.x

The family of lipid kinases termed phosphoinositide-3-kinase (PI3K) is known to contribute at multiple levels to innate and adaptive immune responses, and is hence an attractive target for drug discovery in inflammatory and autoimmune disease, including respiratory diseases. The development of isoform-selective pharmacological inhibitors, targeted gene manipulation and short interfering RNA (siRNA) target validation have facilitated a better understanding of the role that each member of this family of kinases plays in the physiology and pathology of the respiratory system. In this review, we will evaluate the evidence for the roles of specific PI3K isoforms in the lung and airways, and discuss their potential as targets for novel drug therapies.